Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of TGFβR1 via up regulation of its target gene, 22/February/2014, 22.42

Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of TGFβR1 via up regulation of its target gene, 22/February/2014, 22.42

Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of TGFβR1 via up regulation of its target gene, 22/February/2014, 22.42 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Cancer therapy: The anti-cancer drug Campothecin (CPT) suppresses the expression of TGFβR1 via up regulation of its target gene, 22/February/2014, 22.42, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation